 | • レポートコード：MRC2-11QY09142 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はRNA治療薬のグローバル市場について調査・分析したレポートです。種類別（siRNA、ASO、miRNA、核酸アプタマー）市場規模、用途別（がん、糖尿病、結核、循環器疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別RNA治療薬の競争状況、市場シェア ・世界のRNA治療薬市場：種類別市場規模 2015年-2020年（siRNA、ASO、miRNA、核酸アプタマー） ・世界のRNA治療薬市場：種類別市場規模予測 2021年-2026年（siRNA、ASO、miRNA、核酸アプタマー） ・世界のRNA治療薬市場：用途別市場規模 2015年-2020年（がん、糖尿病、結核、循環器疾患、その他） ・世界のRNA治療薬市場：用途別市場規模予測 2021年-2026年（がん、糖尿病、結核、循環器疾患、その他） ・北米のRNA治療薬市場分析：米国、カナダ ・ヨーロッパのRNA治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのRNA治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のRNA治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのRNA治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Roche、Sanofi-Aventis、Abbott Laboratories、Arrowhead Pharmaceuticals、Benitec Biopharma、Calimmune Inc、Dicerna、Gradalis、Quark、RXi、Senesco、Silence Therapeutics、Silenseed、Tekmira、Alnylam Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global RNA Drugs Market
The global RNA Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global RNA Drugs Scope and Market Size
RNA Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global RNA Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the RNA Drugs market is segmented into
siRNA
ASO
miRNA
Nucleic Acid Aptamers
Segment by Application, the RNA Drugs market is segmented into
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Regional and Country-level Analysis
The RNA Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the RNA Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and RNA Drugs Market Share Analysis
RNA Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in RNA Drugs business, the date to enter into the RNA Drugs market, RNA Drugs product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
1 Study Coverage
1.1 RNA Drugs Product Introduction
1.2 Market Segments
1.3 Key RNA Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global RNA Drugs Market Size Growth Rate by Type
1.4.2 siRNA
1.4.3 ASO
1.4.4 miRNA
1.4.5 Nucleic Acid Aptamers
1.5 Market by Application
1.5.1 Global RNA Drugs Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Diabetes
1.5.4 Tuberculosis
1.5.5 Cardiovascular Diseases
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global RNA Drugs Market Size, Estimates and Forecasts
2.1.1 Global RNA Drugs Revenue 2015-2026
2.1.2 Global RNA Drugs Sales 2015-2026
2.2 Global RNA Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global RNA Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global RNA Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global RNA Drugs Competitor Landscape by Players
3.1 RNA Drugs Sales by Manufacturers
3.1.1 RNA Drugs Sales by Manufacturers (2015-2020)
3.1.2 RNA Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 RNA Drugs Revenue by Manufacturers
3.2.1 RNA Drugs Revenue by Manufacturers (2015-2020)
3.2.2 RNA Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global RNA Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by RNA Drugs Revenue in 2019
3.2.5 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 RNA Drugs Price by Manufacturers
3.4 RNA Drugs Manufacturing Base Distribution, Product Types
3.4.1 RNA Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers RNA Drugs Product Type
3.4.3 Date of International Manufacturers Enter into RNA Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global RNA Drugs Market Size by Type (2015-2020)
4.1.1 Global RNA Drugs Sales by Type (2015-2020)
4.1.2 Global RNA Drugs Revenue by Type (2015-2020)
4.1.3 RNA Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global RNA Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global RNA Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global RNA Drugs Revenue Forecast by Type (2021-2026)
4.2.3 RNA Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global RNA Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global RNA Drugs Market Size by Application (2015-2020)
5.1.1 Global RNA Drugs Sales by Application (2015-2020)
5.1.2 Global RNA Drugs Revenue by Application (2015-2020)
5.1.3 RNA Drugs Price by Application (2015-2020)
5.2 RNA Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global RNA Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global RNA Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global RNA Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America RNA Drugs by Country
6.1.1 North America RNA Drugs Sales by Country
6.1.2 North America RNA Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America RNA Drugs Market Facts & Figures by Type
6.3 North America RNA Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe RNA Drugs by Country
7.1.1 Europe RNA Drugs Sales by Country
7.1.2 Europe RNA Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe RNA Drugs Market Facts & Figures by Type
7.3 Europe RNA Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific RNA Drugs by Region
8.1.1 Asia Pacific RNA Drugs Sales by Region
8.1.2 Asia Pacific RNA Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific RNA Drugs Market Facts & Figures by Type
8.3 Asia Pacific RNA Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America RNA Drugs by Country
9.1.1 Latin America RNA Drugs Sales by Country
9.1.2 Latin America RNA Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America RNA Drugs Market Facts & Figures by Type
9.3 Central & South America RNA Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa RNA Drugs by Country
10.1.1 Middle East and Africa RNA Drugs Sales by Country
10.1.2 Middle East and Africa RNA Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa RNA Drugs Market Facts & Figures by Type
10.3 Middle East and Africa RNA Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer RNA Drugs Products Offered
11.1.5 Pfizer Related Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Description and Business Overview
11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Roche RNA Drugs Products Offered
11.2.5 Roche Related Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Description and Business Overview
11.3.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi-Aventis RNA Drugs Products Offered
11.3.5 Sanofi-Aventis Related Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Description and Business Overview
11.4.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abbott Laboratories RNA Drugs Products Offered
11.4.5 Abbott Laboratories Related Developments
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Corporation Information
11.5.2 Arrowhead Pharmaceuticals Description and Business Overview
11.5.3 Arrowhead Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Arrowhead Pharmaceuticals RNA Drugs Products Offered
11.5.5 Arrowhead Pharmaceuticals Related Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Corporation Information
11.6.2 Benitec Biopharma Description and Business Overview
11.6.3 Benitec Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Benitec Biopharma RNA Drugs Products Offered
11.6.5 Benitec Biopharma Related Developments
11.7 Calimmune Inc
11.7.1 Calimmune Inc Corporation Information
11.7.2 Calimmune Inc Description and Business Overview
11.7.3 Calimmune Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Calimmune Inc RNA Drugs Products Offered
11.7.5 Calimmune Inc Related Developments
11.8 Dicerna
11.8.1 Dicerna Corporation Information
11.8.2 Dicerna Description and Business Overview
11.8.3 Dicerna Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Dicerna RNA Drugs Products Offered
11.8.5 Dicerna Related Developments
11.9 Gradalis
11.9.1 Gradalis Corporation Information
11.9.2 Gradalis Description and Business Overview
11.9.3 Gradalis Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Gradalis RNA Drugs Products Offered
11.9.5 Gradalis Related Developments
11.10 Quark
11.10.1 Quark Corporation Information
11.10.2 Quark Description and Business Overview
11.10.3 Quark Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Quark RNA Drugs Products Offered
11.10.5 Quark Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer RNA Drugs Products Offered
11.1.5 Pfizer Related Developments
11.12 Senesco
11.12.1 Senesco Corporation Information
11.12.2 Senesco Description and Business Overview
11.12.3 Senesco Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Senesco Products Offered
11.12.5 Senesco Related Developments
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Corporation Information
11.13.2 Silence Therapeutics Description and Business Overview
11.13.3 Silence Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Silence Therapeutics Products Offered
11.13.5 Silence Therapeutics Related Developments
11.14 Silenseed
11.14.1 Silenseed Corporation Information
11.14.2 Silenseed Description and Business Overview
11.14.3 Silenseed Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Silenseed Products Offered
11.14.5 Silenseed Related Developments
11.15 Tekmira
11.15.1 Tekmira Corporation Information
11.15.2 Tekmira Description and Business Overview
11.15.3 Tekmira Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Tekmira Products Offered
11.15.5 Tekmira Related Developments
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Corporation Information
11.16.2 Alnylam Pharmaceuticals Description and Business Overview
11.16.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Alnylam Pharmaceuticals Products Offered
11.16.5 Alnylam Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 RNA Drugs Market Estimates and Projections by Region
12.1.1 Global RNA Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global RNA Drugs Revenue Forecast by Regions 2021-2026
12.2 North America RNA Drugs Market Size Forecast (2021-2026)
12.2.1 North America: RNA Drugs Sales Forecast (2021-2026)
12.2.2 North America: RNA Drugs Revenue Forecast (2021-2026)
12.2.3 North America: RNA Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe RNA Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: RNA Drugs Sales Forecast (2021-2026)
12.3.2 Europe: RNA Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: RNA Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific RNA Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: RNA Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: RNA Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: RNA Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America RNA Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: RNA Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: RNA Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: RNA Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa RNA Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: RNA Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: RNA Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: RNA Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key RNA Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 RNA Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. RNA Drugs Market Segments
Table 2. Ranking of Global Top RNA Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global RNA Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of siRNA
Table 5. Major Manufacturers of ASO
Table 6. Major Manufacturers of miRNA
Table 7. Major Manufacturers of Nucleic Acid Aptamers
Table 8. Global RNA Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global RNA Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global RNA Drugs Sales by Regions 2015-2020 (K Units)
Table 11. Global RNA Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global RNA Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global RNA Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global RNA Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global RNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global RNA Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Drugs as of 2019)
Table 17. RNA Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. RNA Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers RNA Drugs Price (2015-2020) (USD/Unit)
Table 20. RNA Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers RNA Drugs Product Type
Table 22. Date of International Manufacturers Enter into RNA Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global RNA Drugs Sales by Type (2015-2020) (K Units)
Table 25. Global RNA Drugs Sales Share by Type (2015-2020)
Table 26. Global RNA Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global RNA Drugs Revenue Share by Type (2015-2020)
Table 28. RNA Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global RNA Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global RNA Drugs Sales Share by Application (2015-2020)
Table 31. North America RNA Drugs Sales by Country (2015-2020) (K Units)
Table 32. North America RNA Drugs Sales Market Share by Country (2015-2020)
Table 33. North America RNA Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America RNA Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America RNA Drugs Sales by Type (2015-2020) (K Units)
Table 36. North America RNA Drugs Sales Market Share by Type (2015-2020)
Table 37. North America RNA Drugs Sales by Application (2015-2020) (K Units)
Table 38. North America RNA Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe RNA Drugs Sales by Country (2015-2020) (K Units)
Table 40. Europe RNA Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe RNA Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe RNA Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe RNA Drugs Sales by Type (2015-2020) (K Units)
Table 44. Europe RNA Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe RNA Drugs Sales by Application (2015-2020) (K Units)
Table 46. Europe RNA Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific RNA Drugs Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific RNA Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific RNA Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific RNA Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific RNA Drugs Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific RNA Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific RNA Drugs Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific RNA Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America RNA Drugs Sales by Country (2015-2020) (K Units)
Table 56. Latin America RNA Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa RNA Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America RNA Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America RNA Drugs Sales by Type (2015-2020) (K Units)
Table 60. Latin America RNA Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America RNA Drugs Sales by Application (2015-2020) (K Units)
Table 62. Latin America RNA Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa RNA Drugs Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa RNA Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa RNA Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa RNA Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa RNA Drugs Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa RNA Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa RNA Drugs Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa RNA Drugs Sales Market Share by Application (2015-2020)
Table 71. Pfizer Corporation Information
Table 72. Pfizer Description and Major Businesses
Table 73. Pfizer RNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Pfizer Product
Table 75. Pfizer Recent Development
Table 76. Roche Corporation Information
Table 77. Roche Description and Major Businesses
Table 78. Roche RNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Roche Product
Table 80. Roche Recent Development
Table 81. Sanofi-Aventis Corporation Information
Table 82. Sanofi-Aventis Description and Major Businesses
Table 83. Sanofi-Aventis RNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Sanofi-Aventis Product
Table 85. Sanofi-Aventis Recent Development
Table 86. Abbott Laboratories Corporation Information
Table 87. Abbott Laboratories Description and Major Businesses
Table 88. Abbott Laboratories RNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Abbott Laboratories Product
Table 90. Abbott Laboratories Recent Development
Table 91. Arrowhead Pharmaceuticals Corporation Information
Table 92. Arrowhead Pharmaceuticals Description and Major Businesses
Table 93. Arrowhead Pharmaceuticals RNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Arrowhead Pharmaceuticals Product
Table 95. Arrowhead Pharmaceuticals Recent Development
Table 96. Benitec Biopharma Corporation Information
Table 97. Benitec Biopharma Description and Major Businesses
Table 98. Benitec Biopharma RNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Benitec Biopharma Product
Table 100. Benitec Biopharma Recent Development
Table 101. Calimmune Inc Corporation Information
Table 102. Calimmune Inc Description and Major Businesses
Table 103. Calimmune Inc RNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Calimmune Inc Product
Table 105. Calimmune Inc Recent Development
Table 106. Dicerna Corporation Information
Table 107. Dicerna Description and Major Businesses
Table 108. Dicerna RNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Dicerna Product
Table 110. Dicerna Recent Development
Table 111. Gradalis Corporation Information
Table 112. Gradalis Description and Major Businesses
Table 113. Gradalis RNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Gradalis Product
Table 115. Gradalis Recent Development
Table 116. Quark Corporation Information
Table 117. Quark Description and Major Businesses
Table 118. Quark RNA Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Quark Product
Table 120. Quark Recent Development
Table 121. RXi Corporation Information
Table 122. RXi Description and Major Businesses
Table 123. RXi RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. RXi Product
Table 125. RXi Recent Development
Table 126. Senesco Corporation Information
Table 127. Senesco Description and Major Businesses
Table 128. Senesco RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Senesco Product
Table 130. Senesco Recent Development
Table 131. Silence Therapeutics Corporation Information
Table 132. Silence Therapeutics Description and Major Businesses
Table 133. Silence Therapeutics RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Silence Therapeutics Product
Table 135. Silence Therapeutics Recent Development
Table 136. Silenseed Corporation Information
Table 137. Silenseed Description and Major Businesses
Table 138. Silenseed RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Silenseed Product
Table 140. Silenseed Recent Development
Table 141. Tekmira Corporation Information
Table 142. Tekmira Description and Major Businesses
Table 143. Tekmira RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 144. Tekmira Product
Table 145. Tekmira Recent Development
Table 146. Alnylam Pharmaceuticals Corporation Information
Table 147. Alnylam Pharmaceuticals Description and Major Businesses
Table 148. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 149. Alnylam Pharmaceuticals Product
Table 150. Alnylam Pharmaceuticals Recent Development
Table 151. Global RNA Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 152. Global RNA Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 153. Global RNA Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 154. Global RNA Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 155. North America: RNA Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 156. North America: RNA Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Europe: RNA Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 158. Europe: RNA Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Asia Pacific: RNA Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 160. Asia Pacific: RNA Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 161. Latin America: RNA Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 162. Latin America: RNA Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Middle East and Africa: RNA Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 164. Middle East and Africa: RNA Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 166. Key Challenges
Table 167. Market Risks
Table 168. Main Points Interviewed from Key RNA Drugs Players
Table 169. RNA Drugs Customers List
Table 170. RNA Drugs Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Drugs Product Picture
Figure 2. Global RNA Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. siRNA Product Picture
Figure 4. ASO Product Picture
Figure 5. miRNA Product Picture
Figure 6. Nucleic Acid Aptamers Product Picture
Figure 7. Global RNA Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Cancer
Figure 9. Diabetes
Figure 10. Tuberculosis
Figure 11. Cardiovascular Diseases
Figure 12. Others
Figure 13. RNA Drugs Report Years Considered
Figure 14. Global RNA Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global RNA Drugs Sales 2015-2026 (K Units)
Figure 16. Global RNA Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global RNA Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global RNA Drugs Sales Market Share by Region in 2019
Figure 19. Global RNA Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global RNA Drugs Revenue Market Share by Region in 2019
Figure 21. Global RNA Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by RNA Drugs Revenue in 2019
Figure 23. RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global RNA Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global RNA Drugs Sales Market Share by Type in 2019
Figure 26. Global RNA Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global RNA Drugs Revenue Market Share by Type in 2019
Figure 28. Global RNA Drugs Market Share by Price Range (2015-2020)
Figure 29. Global RNA Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global RNA Drugs Sales Market Share by Application in 2019
Figure 31. Global RNA Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global RNA Drugs Revenue Market Share by Application in 2019
Figure 33. North America RNA Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America RNA Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America RNA Drugs Sales Market Share by Country in 2019
Figure 36. North America RNA Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America RNA Drugs Market Share by Type in 2019
Figure 42. North America RNA Drugs Market Share by Application in 2019
Figure 43. Europe RNA Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe RNA Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe RNA Drugs Sales Market Share by Country in 2019
Figure 46. Europe RNA Drugs Revenue Market Share by Country in 2019
Figure 47. Germany RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. France RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe RNA Drugs Market Share by Type in 2019
Figure 58. Europe RNA Drugs Market Share by Application in 2019
Figure 59. Asia Pacific RNA Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific RNA Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific RNA Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific RNA Drugs Revenue Market Share by Region in 2019
Figure 63. China RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. China RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. India RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific RNA Drugs Market Share by Type in 2019
Figure 86. Asia Pacific RNA Drugs Market Share by Application in 2019
Figure 87. Latin America RNA Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America RNA Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America RNA Drugs Sales Market Share by Country in 2019
Figure 90. Latin America RNA Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America RNA Drugs Market Share by Type in 2019
Figure 98. Latin America RNA Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa RNA Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa RNA Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa RNA Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa RNA Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E RNA Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E RNA Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa RNA Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa RNA Drugs Market Share by Application in 2019
Figure 111. North America RNA Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America RNA Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe RNA Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe RNA Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific RNA Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific RNA Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America RNA Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America RNA Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa RNA Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa RNA Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…- 糖尿病治療装置・薬剤の世界市場（～2026年） Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs. The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet. Market Analysis an…
- 結核治療薬の世界市場（～2026年） Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes, or talks. Market Analysis and Insight…
- 中枢神経系疾患治療薬の世界市場（～2026年） A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous system Market Analysis and Insights: Global Drugs for Central Nervous System Diseases Market The global Drugs for Central Nervous System Diseases market size is projected to reac…
- 頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…